Skip to content

Clinical trials

Recruiting Bronchial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Neoplasms Status: Recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20211
20221
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Iovance Biotherapeutics, Inc.2
ArriVent BioPharma, Inc.1
AstraZeneca1
Eli Lilly and Company1
Nanfang Hospital, Southern Medical University1
Revolution Medicines, Inc.1
Turning Point Therapeutics, Inc.1
VA Office of Research and Development1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Neoplasms10
Lung Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Lung Diseases8
Neoplasms8
Respiratory Tract Neoplasms7
Carcinoma, Bronchogenic6
Neoplasms by Site6
Respiratory Tract Diseases6
Thoracic Neoplasms6

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.